Question

ACTEMRA 200MG SDV 10ML

5 0242-0136-01

$      1,268.19

*

BLENREP 100MG/VIAL SDV

0 0173-0896-01

$      9,999.00

*

BLINCYTO 35 MCG SDV

5 5513-0160-01

$      4,406.34

*

CYCLOMYDRIL 02/1% Sol 2 ML

0 0065-0359-02

$            32.50

*

DEXAMETHASONE 10 MG-ML VL 25X1 ML

0 0641-0367-25

$            29.00

*

EXPAREL 1.3% 266 MG SDV

6 5250-0266-09

$      4,177.50

*

HUMIRA CF 10MG/0.1ML PFS KIT 2

0 0074-0817-02

$      5,990.42

*

HUMIRA CF 20MG/0.2ML PFS KIT 2

0 0074-0616-02

$      5,990.42

*

LIOTHRONINE SODIUM 5MCG TAB 90

4 2794-0018-12

$            43.00

*

NEUPOGEN 480000 CG/1.6 VL 10X1.6 ML

5 5513-0546-10

$      5,404.33

*

PIPERACIL/TAZ 4.5 GM VL 10

5 5150-0121-50

$            65.00

*

PIPERACILLIN-TAZOBACTAM 4.5GM SDV 10

6 4679-0012-01

$            65.00

*

POLYMYXIN B SULFATE 500 MU VL 10

6 3323-0367-11

$          169.00

*

PROGESTERONE 50 MG-ML OIL VL 10 ML

0 0591-3128-79

$            47.50

*

REBINYN KIT 478 IU VL

0 0169-7905-01

$      2,234.65

*

TIBSOVO 250 MG MM

7133-4100-01

$    37,695.00

*

Answer 1

BACTERIOSTATIC SODIUM CHLORIDE (Hospira) (sodium chloride) 0.9% SOL FOR INJ 25 X 30ML MULTIPLE DOSE VIAL

0 0409-1966-07

$            27.75

*

CYCLOMYDRIL 02/1% Sol 2 ML

0 0065-0359-02

$            32.50

*

DEXAMETHASONE 10 MG-ML VL 25X1 ML

0 0641-0367-25

$            32.75

*

DIPHENHYDRAMINE HCL 50 MG-ML VL 25X1 ML

0 0641-0376-25

$            32.00

*

PIPERACIL/TAZ 4.5 GM VL 10

0 0781-3114-95

$            65.00

*

PIPERACILLIN-TAZOBACTAM 4.5GM SDV 10

6 4679-0012-01

$            65.00

*

RITUXAN 100MG VL 10ML

5 0242-0051-21

$      1,081.00

*

TABRECTA 200MG TABLET 56/EA

       78-0716-56

$    10,367.00

*

VORAXAZE 1000UNITS VL 1 DS

5 0633-0210-11

$    45,656.00

Comments

Item Description

NDC/UPC

Price

ACTEMRA 400MG/20ML SINGLE-USE

5 0242-0137-01

$      2,664.00

*

ALBUMIN (HUMAN) 5% 12.5G/250ML x 1 BOTTLE

6 8982-0623-02

$            48.00

*

AUSTEDO 12 MG TAB 60

6 8546-0172-60

$      6,406.00

*

AVASTIN 100MG VIAL

5 0242-0060-01

$          917.00

*

CYCLOMYDRIL 02/1% Sol 2 ML

0 0065-0359-02

$            32.50

*

DEXAMETHASONE 10 MG-ML VL 25X1 ML

0 0641-0367-25

$            32.75

*

DIPHENHYDRAMINE HCL 50 MG-ML VL 25X1 ML

0 0641-0376-25

$            32.00

*

EXPAREL 1.3% 266 MG SDV

6 5250-0266-09

$      4,177.50

*

MULTIVITAMIN + ZINC CHEWABLE TABLET

5 8914-0014-60

$            37.50

*

PADCEV 20 MG

5114-4020-01

$      4,544.00

*

PADCEV 30 MG

5114-4030-01

$      6,038.00

*

PHENELZINE SULFATE 15MG TAB #60 LUPIN

4 3386-0360-21

$            49.00

*

REBLOZYL 25MG DSHP SPD

5 9572-0711-01

$      3,785.30

*

TABRECTA 200MG TABLET 56/EA

0 0078-0716-56

$    10,300.00

*

TECENTRIQ 60MG/ML 20ML SPD

5 0242-0917-01

$    10,113.43

---

2020 年通过 FDA 审批的药物
No
.
Drug
Name/药
名
Active Ingredient/活
性成分
Approval
Date 批准
日期
FDA-approved use on approval
date/FDA 批准用途
1 Gallium 68
PSMA-11
Gallium 68 PSMA-11 12/1/2020 For detection and localization of
prostate cancer
2 Danyelza naxitamab-gqgk 11/25/2020 To treat high-risk refractory or
relapsed neuroblastoma
3 Imcivree setmelanotide 11/25/2020 To treat obesity and the control of
hunger associated with proopiomelanocortin deficiency, a rare
disorder that causes severe obesity
that begins at an early age
4 Oxlumo lumasiran 11/23/2020 To treat hyperoxaluria type 1
5 Zokinvy lonafarnib 11/20/2020 To treat rare conditions related to
premature aging
6 Veklury remdesivir 10/22/2020 To treat COVID-19
7 Inmazeb atoltivimab,
maftivimab, and
odesivimab-ebgn
10/14/2020 To treat ebola virus
8 Gavreto pralsetinib 9/4/2020 To treat non-small lung cancer
9 Detectnet copper Cu 64 dotatate
injection
9/3/2020 To help detect certain types of
neuroendocrine tumors
10 Sogroya somapacitan-beco 8/28/2020 Growth hormone
11 Winlevi clascoterone 8/26/2020 To treat acne
12 Enspryng satralizumab-mwge 8/14/2020 To treat neuromyelitis optica spectrum
disorder
13 Viltepso viltolarsen 8/12/2020 To treat Duchenne muscular dystrophy
14 Olinvyk oliceridine 8/7/2020 To manage acute pain in certain adults
15 Evrysdi risdiplam 8/7/2020 To treat spinal muscular atrophy
16 Lampit nifurtimox 8/6/2020 To treat Chagas disease in certain
pediatric patients younger than age 18
17 Blenrep belantamab
mafodotin-blmf
8/5/2020 To treat multiple myeloma
18 Monjuvi tafasitamab-cxix 7/31/2020 To treat relapsed or refractory diffuse
large B-cell lymphoma
19 Xeglyze abametapir 7/24/2020 To treat head lice
20 Inqovi decitabine and
cedazuridine
7/7/2020 To treat adult patients with
myelodysplastic syndromes
21 Rukobia fostemsavir 7/2/2020 To treat HIV
22 Byfavo remimazolam 7/2/2020 For sedation
23 Dojolvi triheptanoin 6/30/2020 To treat molecularly long-chain fatty
acid oxidation disorders
24 Zepzelca lurbinectedin 6/15/2020 To treat metastatic small cell lung
cancer
25 Uplizna inebilizumab-cdon 6/11/2020 To treat neuromyelitis optica spectrum
disorder
26 Tauvid flortaucipir F18 5/28/2020 Diagnostic agent for patients with
Alzheimer’s disease
3
27 Artesunate artesunate 5/26/2020 To treat severe malaria
28 Cerianna fluoroestrdiol F18 5/20/2020 Diagnostic imaging agent for certain
patients with breast cancer
29 Qinlock ripretinib 5/15/2020 To treat advanced gastrointestinalstromal tumors
30 Retevmo selpercatinib 5/8/2020 To treat lung and thyroid cancers
31 Tabrecta capmatinib 5/6/2020 To treat patients with non small cell
lung cancer
32 Ongentys opicapone 4/24/2020 To treat patients with Parkinson’s
disease experiencing “off” episodes
33 Trodelvy sacituzumab
govitecan-hziy
4/22/2020 To treat adult patients with metastatic
triple-negative breast cancer who
received at least two prior therapies
for metastatic disease
34 Pemazyre pemigatinib 4/17/2020 To treat certain patients with
cholangiocarcinoma, a rare form of
cancer that forms in bile ducts
35 Tukysa tucatinib 4/17/2020 To treat advanced unresectable or
metastatic HER2-positive breast
cancer
36 Koselugo selumetinib 4/10/2020 To treat neurofibromatosis type 1, a
genetic disorder of the nervous system
causing tumors to grow on nerves
37 Zeposia ozanimod 3/25/2020 To treat relapsing forms of multiple
sclerosis
38 Isturisa osilodrostat 3/6/2020 To treat adults with Cushing’s disease
who either cannot undergo pituitary
gland surgery or have undergone the
surgery but still have the disease
39 Sarclisa isatuximab 3/2/2020 To treat multiple myloma
40 Nurtec
ODT
rimegepant 2/27/2020 To treat migraine
41 Barhemsys amisulpride 2/26/2020 To help prevent nausea and vomiting
after surgery
42 Vyepti eptinezumab-jjmr 2/21/2020 For the preventive treatment of
migraine in adults
43 Nexletol bempedoic acid 2/21/2020 To treat adults with heterozygous
familial hypercholesterolemia or
established atherosclerotic
cardiovascular disease who require
additional lowering of LDL-C
44 Pizensy lactitol 2/12/2020 To treat chronic idiopathic
constipation (CIC) in adults
45 Tazverik tazemetostat 1/23/2020 To treat epithelioid sarcoma
46 Tepezza teprotumumab-trbw 1/21/2020 To treat Thyroid eye disease
47 Ayvakit avapritinib 1/9/2020 To treat adults with unresectable or
metastatic gastrointestinal stromal
tumor (GIST)

---

48 Ubrelvy ubrogepant 12/23/2019 to treat acute treatment of
migraine with or without aura
in adults
49 Enhertu fam-trastuzumab deruxtecannxki
12/20/2019 To treat metastatic breast
cancer
50 Dayvigo lemborexant 12/20/2019 To treat insomnia
51 Caplyta lumateperone tosylate 12/20/2019 To treat schizophrenia
52 TissueBlu
e
Brilliant Blue G Ophthalmic
Solution
12/20/2019 Dye used in eye surgery
53 Padcev enfortumab vedotin-ejfv 12/18/2019 To treat refractory bladder
cancer
54 Vyondys
53
golodirsen 12/12/2019 To treat certain patients with
Duchenne muscular
dystrophy
55 Oxbryta voxelotor 11/25/2019 To treat sickle cell disease
56 Xcopri cenobamate 11/21/2019 To treat partial onset seizures
57 Givlaari givosiran 11/20/2019 To treat acute hepatic
porphyria, a rare blood
disorder
58 Adakveo crizanlizumab-tmca 11/15/2019 To treat patients with painful
complication of sickle cell
disease
59 Fetroja cefiderocol 11/14/2019 To treat patients with
complicated urinary tract
infections who have limited or
no alternative treatment
options
60 Brukinsa zanubrutinib 11/14/2019 To treat certain patients with
mantle cell lymphoma, a form
of blood cancer
61 Reblozyl luspatercept–aamt 11/8/2019 For the treatment of anemia
in adult patients with beta
thalassemia who require
regular red blood cell
transfusions
62 ExEm
Foam
air polymer-type A 11/7/2019 A diagnostic agent used to
assess fallopian tube patency
(openness) in women with
known or suspected infertility
63 Trikafta elexacaftor/ivacaftor/tezacafto
r
10/21/2019 To treat patients 12 years of
age and older with the most
common gene mutation that
causes cystic fibrosis
64 Reyvow lasmiditan 10/11/2019 For the acute treatment of
migraine with or without
aura, in adults
5
65 fluorodopa F 18 10/10/2019 A diagnostic agent for use in
positron emission
tomography (PET) to help
diagnose adult patients with
suspected Parkinsonian
syndromes (PS)
66 Scenesse afamelanotide 10/8/2019 To increase pain-free light
exposure in adult patients
with a history of phototoxic
reactions (damage to skin)
from erythropoietic
protoporphyria
67 Beovu brolucizumab–dbll 10/7/2019 Treatment of wet age-related
macular degeneration
68 Aklief trifarotene 10/4/2019 For the topical treatment of
acne vulgaris in patients 9
years of age and older
69 Ibsrela tenapanor 9/12/2019 To treat irritable bowel
syndrome with constipation in
adults.
70 Nourianz istradefylline 8/27/2019 To treat adult patients with
Parkinson’s disease
experiencing “off” episodes
71 Ga-68-
DOTATOC
Ga-68-DOTATOC 8/21/2019 For use with positron
emission tomography (PET)
for localization of
somatostatin receptor
positive neuroendocrine
tumors (NETs)
72 Xenleta lefamulin 8/19/2019 To treat adults with
community-acquired bacterial
pneumonia
73 Rinvoq upadacitinib 8/16/2019 To treat adults with
moderately to severely active
rheumatoid arthritis
74 Inrebic fedratinib 8/16/2019 To treat adult patients with
intermediate-2 or high-risk
primary or secondary
myelofibrosis
75 Rozlytrek entrectinib 8/15/2019 To treat adult patients with
metastatic non-small cell lung
cancer (NSCLC) whose tumors
are ROS1-positive
76 Wakix pitolisant 8/14/2019 To treat excessive daytime
sleepiness (EDS) in adult
patients with narcolepsy
77 pretomanid 8/14/2019 For treatment-resistant forms
of tuberculosis that affects
the lungs
6
78 Turalio pexidartinib 8/2/2019 To treat adult patients with
symptomatic tenosynovial
giant cell tumor
79 Nubeqa darolutamide 7/30/2019 To treat adult patients with
non-metastatic castration
resistant prostate cancer
80 Accrufer ferric maltol 7/25/2019 To treat iron deficiency
anemia in adults
81 Recarbrio imipenem, cilastatin and
relebactam
7/16/2019 To treat complicated urinary
tract and complicated intraabdominal infections
82 Xpovio selinexor 7/3/2019 To treat adult patients with
relapsed or refractory
multiple myeloma (RRMM)
83 Vyleesi bremelanotide 6/21/2018 To treat hypoactive sexual
desire disorder in
premenopausal women.
84 Polivy polatuzumab vedotin-piiq 6/10/2019 To treat adult patients with
relapsed or refractory diffuse
large B-cell lymphoma
85 Piqray alpelisib 5/24/2019 To treat breast cancer
86 Vyndaqel tafamidis meglumine 5/3/2019 To treat heart disease
(cardiomyopathy) caused by
transthyretin mediated
amyloidosis (ATTR-CM) in
adults
87 Skyrizi risankizumab-rzaa 4/23/2019 To treat moderate-to-severe
plaque psoriasis in adults who
are candidates for systemic
therapy or phototherapy
88 Balversa erdafitinib 4/12/2019 To treat adult patients with
locally advanced or metastatic
bladder cancer
89 Evenity romosozumab-aqqg 4/9/2019 To treat osteoporosis in
postmenopausal women at
high risk of fracture
90 Mayzent siponimod 3/26/2019 To treat adults with relapsing
forms of multiple sclerosis
91 Sunosi solriamfetol 3/20/2019 To treat excessive sleepiness
in adult patients with
narcolepsy or obstructive
sleep apnea
92 Zulresso brexanolone 3/19/2019 To treat postpartum
depression (PPD) in adult
women
93 Egaten triclabendazole 2/13/2019 To treat fascioliasis, a
parasitic infestation caused by
two species of flatworms or
trematodes that mainly the
affect the liver, sometimes
referred to as “liver flukes”
7
94 Cablivi caplacizumab-yhdp 2/6/2019 To treat adult patients with
acquired thrombotic
thrombocytopenic purpura
(aTTP)
95 Jeuveau prabotulinumtoxinA-xvfs 2/1/2019 For the temporary
improvement in the
appearance of moderate to
severe glabellar lines
associated with corrugator
and/or procerus muscle
activity in adult patients

---

96 Ultomiris ravulizumab 12/21/2018 To treat paroxysmal nocturnal
hemoglobinuria (PNH)
97 Elzonris tagraxofusp-erzs 12/21/2018 To treat blastic plasmacytoid
dendritic cell neoplasm
(BPDCN)
98 Asparlas calaspargase pegolmknl
12/20/2018 To treat acute lymphoblastic
leukemia (ALL) in pediatric and
young adult patients age 1
month to 21 years
99 Motegrity prucalopride 12/14/2018 To treat chronic idiopathic
constipation
100 Xospata gilteritinib 11/28/2018 To treat patients who have
relapsed or refractory acute
myeloid leukemia (AML)
101 Firdapse amifampridine 11/28/2028 To treat Lambert-Eaton
myasthenic syndrome (LEMS) in
adults
102 Vitrakvi larotrectinib 11/26/2018 To treat patients whose cancers
have a specific genetic feature
(biomarker)
103 Daurismo glasdegib 11/21/2018 To treat newly-diagnosed acute
myeloid leukemia (AML) in
adult patients
104 Gamifant emapalumablzsgemapalumab-lzsg
11/20/2018 To treat primary
hemophagocytic
lymphohistiocytosis (HLH)
105 Aemcolo rifamycin 11/16/2018 To treat travelers’ diarrhea
106 Yupelri revefenacin 11/9/2018 To treat patients with chronic
obstructive pulmonary disease
(COPD)
107 Lorbrena lorlatinib 11/2/2018 To treat patients with
anaplastic lymphoma kinase
(ALK)-positive metastatic nonsmall cell lung cancer
108 Xofluza baloxavir marboxil 10/24/2018 To treat acute uncomplicated
influenza in patients who have
been symptomatic for no more
than 48 hours.
109 Talzenna talazoparib 10/16/2018 To treat locally advanced or
metastatic breast cancer
patients with a germline BRCA
mutation.
110 Tegsedi inotersen 10/5/2018 To treat polyneuropathy of
hereditary transthyretinmediated amyloidosis in adults
9
111 Revcovi elapegademase-lvlr 10/5/2018 To treat Adenosine DeaminaseSevere Combined
Immunodeficiency (ADA-SCID)
112 Nuzyra omadacycline 10/2/2018 To treat community-acquired
bacterial pneumonia and acute
bacterial skin and skin structure
infections
113 Seysara sarecycline 10/1/2018 To treat inflammatory lesions of
non-nodular moderate to
severe acne vulgaris in patients
9 years of age and older
114 Libtayo cemiplimab-rwlc 9/28/2018 To treat cutaneous squamous
cell carcinoma (CSCC)
115 VizimproExterna
l Link Disclaimer
dacomitinib 9/27/2018 To treat metastatic non-smallcell lung cancer
116 Emgality galcanezumab-gnlm 9/27/2018 For the preventive treatment of
migraine in adults
117 Copiktra duvelisib 9/24/2018 To treat relapsed or refractory
chronic lymphocytic leukemia,
small lymphocytic lymphoma
and follicular lymphoma
118 Ajovy fremanezumab-vfrm 9/14/2018 For the preventive treatment of
migraine in adults
119 Lumoxiti moxetumomab
pasudotox-tdfk
9/13/2018 To treat hairy cell leukemia
120 Pifeltro doravirine 8/30/2018 To treat HIV-1 infection in adult
patients
121 Xerava eravacycline 8/27/2018 To treat complicated intraabdominal infections in patients
18 years of age and older
122 Takhzyro lanadelumab 8/23/2018 To treat types I and II hereditary
angioedema
123 Oxervate cenegermin-bkbj 8/22/2018 To treat neurotrophic keratitis
124 Diacomit stiripentol 8/20/2018 To treat seizures associated
with Dravet syndrome in
patients 2 years of age and
older taking clobazam
125 Galafold migalastat 8/10/2018 To treat treat adults with Fabry
disease.
126 Annovera segesterone acetate
and ethinyl estradiol
vaginal system
8/10/2018 New vaginal ring used to
prevent pregnancy for an
entire year
127 Onpattro patisiran 8/10/2018 To treat the polyneuropathy of
hereditary transthyretinmediated amyloidosis in adult
patients
128 Poteligeo mogamulizumab-kpkc 8/8/2018 To treat two rare types of nonHodgkin lymphoma
129 Mulpleta lusutrombopag 7/31/2018 To treat thrombocytopenia in
adult patients with chronic liver
10
disease who are scheduled to
undergo a procedure
130 Omegaven fish oil triglycerides 7/27/2018 As a source of calories and fatty
acids in pediatric patients with
parenteral nutrition-associated
cholestasis
131 Orilissa elagolix sodium 7/23/2018 For the management of
moderate to severe pain
associated with endometriosis
132 Krintafel tafenoquine 7/20/2018 For the radical cure (prevention
of relapse) of Plasmodium vivax
malaria
133 Tibsovo ivosidenib 7/20/2018 To treat patients with relapsed
or refractory acute myeloid
leukemia
134 TPOXX tecovirimat 7/13/2018 To treat smallpox
135 Braftovi encorafenib 6/27/2018 To treat unresectable or
metastatic melanoma
136 Mektovi binimetinib 6/27/2018 To treat unresectable or
metastatic melanoma
137 Zemdri plazomicin 6/25/2018 To treat adults with
complicated urinary tract
infections
138 Epidioloex cannabidiol 6/25/2018 To treat rare, severe forms of
epilepsy
139 Moxidectin moxidectin 6/13/2018 To treat onchocerciasis due to
Onchocerca volvulus in patients
aged 12 years and older
140 Olumiant baricitinib 5/31/2018 To treat moderately to severely
active rheumatoid arthritis
141 Palynziq pegvaliase-pqpz 5/24/2018 To treat adults with a rare and
serious genetic disease known
as phenylketonuria (PKU)
142 Doptelet avatrombopag 5/21/2018 To treat low blood platelet
count (thrombocytopenia) in
adults with chronic liver disease
who are scheduled to undergo
a medical or dental procedure
143 Lokelma sodium zirconium
cyclosilicate
5/18/2018 To treat hyperkalemia
144 Aimovig erenumab-aooe 5/17/2018 For the preventive treatment
for migraine
145 Lucemyra lofexidine
hydrochloride
5/16/2018 For the non-opioid treatment
for management of opioid
withdrawal symptoms in adults
146 Akynzeo fosnetupitant and
palonosetron
4/19/2018 To prevent acute and delayed
nausea and vomiting associated
with initial and repeat courses
of highly emetogenic cancer
chemotherapy
11
147 Crysvita burosumab-twza 4/17/2018 To treat adults and children
ages 1 year and older with xlinked hypophosphatemia
(XLH), a rare, inherited form of
rickets
148 Tavalisse fostamatinib 4/17/2018 To treat thrombocytopenia in
adult patients with persistent or
chronic immune
thrombocytopenia (ITP)
149 Ilumya tildrakizumab 3/20/2018 To treat adults with moderateto-severe plaque psoriasis who
are candidates for systemic
therapy or phototherapy
150 Trogarzo ibalizumab-uiyk 3/6/2018 To treat HIV patients who have
limited treatment options
151 Erleada apalutamide 2/14/2018 To treat a certain type of
prostate cancer using novel
clinical trial endpoint
152 Symdeko tezacaftor; ivacaftor 2/12/2018 To treat cystic fibrosis in
patients age 12 years and older
153 Biktarvy bictegravir,
embitcitabine,
tenofovir alafenamide
2/7/2018 To treat infection in adults who
have no antiretroviral
treatment history or to replace
the current antiretroviral
regimen
154 Lutathera lutetium Lu 177
dotatate
1/26/2018 To treat a type of cancer that
affects the pancreas or
gastrointestinal tract called
gastroenteropancreatic
neuroendocrine tumors (GEPNETs).

---

155 Giapreza angiotensin II 12/21/2017 To increase blood pressure in adults
with septic or other distributive shock
156 Macrilen macimorelin acetate 12/20/2017 For the diagnosis of adult growth
hormone deficiency
157 Steglatro ertugliflozin 12/19/2017 To improve glycemic control in adults
with type 2 diabetes mellitus
158 Rhopressa netarsudil 12/18/2017 To treat glaucoma or ocular
hypertension
159 Xepi ozenoxacin 12/11/2017 To treat impetigo
160 Ozempic semaglutide 12/5/2017 To improve glycemic control in adults
with type 2 diabetes mellitus
161 Hemlibra emicizumab 11/16/2017 To prevent or reduce the frequency of
bleeding episodes in adult and
pediatric patients with hemophilia A
who have developed antibodies called
Factor VIII (FVIII) inhibitors.
162 Mepsevii vestronidase alfavjbk
11/15/2017 To treat pediatric and adult patients
with an inherited metabolic condition
called mucopolysaccharidosis type VII
(MPS VII), also known as Sly
syndrome.
163 Fasenra benralizumab 11/14/2017 For add-on maintenance treatment of
patients with severe asthma aged 12
years and older, and with an
eosinophilic phenotype
164 Prevymis letermovir 11/8/2017 To prevent infection after bone
marrow transplant
165 Vyzulta latanoprostene
bunod ophthalmic
solution
11/2/2017 To treat intraocular pressure in
patients with open-angle glaucoma or
ocular hypertension.
166 Calquence acalabrutinib 10/31/2017 To treat adults with mantle cell
lymphoma
167 Verzenio abemaciclib 9/28/2017 To treat certain advanced or
metastatic breast cancers
168 Solosec secnidazole 9/15/2017 To treat bacterial vaginosis
169 Aliqopa copanlisib 9/14/2017 To treat adults with relapsed follicular
lymphoma
170 benznidazol
e
benznidazole 8/29/2017 To treat children ages 2 to 12 years
old with Chagas disease
171 Vabomere meropenem and
vaborbactam
8/29/2017 To treat adults with complicated
urinary tract infections
172 Besponsa inotuzumab
ozogamicin
8/17/2017 To treat adults with relapsed or
refractory acute lymphoblastic
leukemia
173 Mavyret glecaprevir and
pibrentasvir
8/3/2017 To treat adults with chronic hepatitis
C virus
13
174 Idhifa enasidenib 8/1/2017 To treat relapsed or refractory acute
myeloid leukemia
175 Vosevi sofosbuvir,
velpatasvir and
voxilaprevir
7/18/2017 To treat adults with chronic hepatitis
C virus
176 Nerlynx neratinib maleate 7/17/2017 To reduce the risk of breast cancer
returning
177 Tremfya guselkumab 7/13/2017 For the treatment of adult patients
with moderate-to-severe plaque
psoriasis
178 Bevyxxa betrixaban 6/23/2017 For the prophylaxis of venous
thromboembolism (VTE) in adult
patients hospitalized for an acute
medical illness
179 Baxdela delafloxacin 6/19/2017 To treat patients with acute bacterial
skin infections
180 Kevzara sarilumab 5/22/2017 To treat adult rheumatoid arthritis
181 Radicava edaravone 5/5/2017 To treat patients with amyotrophic
lateral sclerosis (ALS)
182 Imfinzi durvalumab 5/1/2017 To treat patients with locally
advanced or metastatic urothelial
carcinoma
183 Tymlos abaloparatide 4/28/2017 To treat osteoporosis in
postmenopausal women at high risk
of fracture or those who have failed
other therapies
184 Rydapt midostaurin 4/28/2017 To treat acute myeloid leukemia,
advanced systemic mastocytosis
185 Alunbrig brigatinib 4/28/2017 To treat patients with anaplastic
lymphoma kinase (ALK)-positive
metastatic non-small cell lung cancer
(NSCLC) who have progressed on or
are intolerant to crizotinib
186 Brineura cerliponase alfa 4/27/2017 To treat a specific form of Batten
disease
187 Ingrezza valbenazine 4/11/2017 To treat adults with tardive
dyskinesia
188 Austedo deutetrabenazine 4/3/2017 For the treatment of chorea
associated with Huntington’s disease
189 Ocrevus ocrelizumab 3/28/2017 To treat patients with relapsing and
primary progressive forms of multiple
sclerosis
190 Dupixent dupilumab 3/28/2017 To treat adults with moderate-tosevere eczema (atopic dermatitis)
191 Zejula niraparib 3/27/2017 For the maintenance treatment for
recurrent epithelial ovarian, fallopian
tube or primary peritoneal cancers
192 Symproic naldemedine 3/23/2017 For the treatment of opioid-induced
constipation
193 Bavencio avelumab 3/23/2017 To treat metastatic Merkel cell
carcinoma
14
194 Xadago safinamide 3/21/2017 To treat Parkinson’s disease
195 Kisqali ribociclib 3/13/2017 To treat postmenopausal women with
a type of advanced breast cancer
196 Xermelo telotristat ethyl 2/28/2017 To treat carcinoid syndrome diarrhea
197 Siliq brodalumab 2/15/2017 To treat adults with moderate-tosevere plaque psoriasis
198 Emflaza deflazacort 2/9/2017 To treat patients age 5 years and
older with Duchenne muscular
dystrophy (DMD)
199 Parsabiv etelcalcetide 2/7/2017 To treat secondary
hyperparathyroidism in adult patients
with chronic kidney disease
undergoing dialysis
200 Trulance plecanatide 1/19/2017 To treat Chronic Idiopathic
Constipation (CIC) in adult patients.

---

201 Spinraza nusinersen 12/23/2016 To treat children and adults with spinal
muscular atrophy (SMA)
202 Rubraca rucaparib 12/19/2016 To treat women with a certain type of
ovarian cancer
203 Eucrisa crisaborole 12/14/2016 To treat mild to moderate eczema (atopic
dermatitis) in patients two years of age and
older
204 Zinplava bezlotoxumab 10/21/2016 To reduce the recurrence of Clostridium
difficile infection in patients aged 18 years or
older
205 Lartruvo olaratumab 10/19/2016 To treat adults with certain types of soft
tissue sarcoma
206 Exondys
51
eteplirsen 9/19/2016 To treat patients with Duchenne muscular
dystrophy
207 Adlyxin lixisenatide 7/27/2016 To improve glycemic control (blood sugar
levels)
208 Xiidra lifitegrast
ophthalmic
solution
7/11/2016 To treat the signs and symptoms of dry eye
disease
209 Epclusa sofosbuvir and
velpatasvir
6/28/2016 To treat all six major forms of hepatitis C
virus
210 NETSPOT gallium Ga 68
dotatate
6/1/2016 A diagnostic imaging agent to detect rare
neuroendocrine tumors
211 Axumin fluciclovine F 18 5/27/2016 A new diagnostic imaging agent to detect
recurrent prostate cancer
212 Ocaliva obeticholic acid 5/27/2016 To treat rare, chronic liver disease
213 Zinbryta daclizumab 5/27/2016 To treat multiple sclerosis
214 Tecentriq atezolizumab 5/18/2016 To treat urothelial carcinoma, the most
common type of bladder cancer
215 Nuplazid pimavanserin 4/29/2016 To treat hallucinations and delusions
associated with psychosis experienced by
some people with Parkinson’s disease
216 Venclext
a
venetoclax 4/11/2016 For chronic lymphocytic leukemia in patients
with a specific chromosomal abnormality
217 Defitelio defibrotide
sodium
3/30/2016 To treat adults and children who
develop hepatic veno-occlusive disease with
additional kidney or lung abnormalities after
they receive a stem cell transplant from
blood or bone marrow called hematopoietic
stem cell transplantation
218 Cinqair reslizumab 3/23/2016 To treat severe asthma
219 Taltz ixekizumab 3/22/2016 To treat adults with moderate-to-severe
plaque psoriasis.
220 Anthim obiltoxaximab 3/18/2016 To treat inhalational anthrax in combination
with appropriate antibacterial drugs.
16
221 Briviact brivaracetam 2/18/2016 To treat partial onset seizures in patients age
16 years and older with epilepsy.
222 Zepatier elbasvir and
grazoprevir
1/28/2016 To treat patients with chronic hepatitis C
virus (HCV) genotypes 1 and 4 infections in
adult patients.

---

Item Description

NDC/UPC

Price

ADCETRIS 50MG VL DS

5114-4050-01

$      9,924.00

*

AUSTEDO 12 MG TAB 60

6 8546-0172-60

$      6,406.00

*

CIDOFOVIR 375 MG-5 ML VL 5 ML

2 3155-0216-31

$          763.00

*

DAPTACEL VL 10X0.5 ML

4 9281-0286-10

$          356.00

*

EXPAREL 1.3% 266 MG SDV

6 5250-0266-09

$      4,177.50

*

EXPAREL 133 MG SDV 4X10ML

6 5250-0133-04

$          908.00

*

HETASTARCH-NS 6% BAG 12X500 ML

0 0409-7248-03

$          191.25

*

KADCYLA 100MG SPD

5 0242-0088-01

$      3,469.94

*

MEGESTROL ACETATE 40 MG TAB 100

4 9884-0290-01

$            16.00

*

MYOBLOC INJ 10000 UNITS 2 .0ML VIAL

1 0454-0712-10

$      1,214.29

*

PADCEV 20 MG

5114-4020-01

$      4,544.00

*

PADCEV 30 MG

5114-4030-01

$      6,210.00

*

PHENELZINE SULFATE 15MG TAB #60 LUPIN

4 3386-0360-21

$            49.00

*

RECOTHROM 5000 UNITS THROMBIN TOPICAL (ADS 201801)

4382-5606-41

$            89.00

*

SODIUM CHLORIDE 0.9% SOLUTION 10

0 0409-4888-10

$            22.75

*

TABRECTA 150 MG TAB 56

0 0078-0709-56

$    10,367.00

*

TABRECTA 200MG TABLET 56/EA

0 0078-0716-56

$    10,367.00

*

TUKYSA 150MG TAB 60

5 1144-0002-60

$    15,698.00

*

TUKYSA 50MG 60 TABS

5 1144-0001-60

$      9,000.00

*

*Pricing assumes at least $10,000 in purchases.  Prices can increase or decrease subject to your total purchase order.

As always if there’s interest please let us know if you would like to purchase!  Prices are subject to change.

---

Please see below for our most sold pharmaceuticals for export last week.

Item Description

NDC/UPC

Price

PHENELZINE SULFATE 15MG TAB #60 LUPIN

4 3386-0360-21

$            49.00

*

RIMABOTULINUM TOXIN 5000 UNITS/ML INJECTION

1 0454-0711-10

$          688.00

*

RITUXAN 500MG/ML - 50ML VIAL

5 0242-0053-06

$      5,426.00

*

SHINGRIX VACCINE KIT 10 DOSES/20 VIALS

5 8160-0823-11

$      1,675.00

*

SODIUM CHLORIDE BACT. 0.9% SDV 25x30ML

0 0409-1966-07

$            27.00

*

TABRECTA 200MG TABLET 56/EA

78-0716-56

$    10,367.00

*

TRODELVY VIAL 180MG SDV SPD

5 5135-0132-01

$      3,696.00

*

TUKYSA 150MG TAB 60

5 1144-0002-60

$    16,158.00

*

TUKYSA 50MG 60 TABS

5 1144-0001-60

$      9,000.00

*

*Pricing assumes at least $10,000 in purchases.  Prices can increase or decrease subject to your total purchase order.

As always if there’s interest please let us know if you would like to purchase!  Prices are subject to change.

Thanks!

---

美国 腹膜透析液 现货Dianeal low calcium with 1.5% Dextrose
Baxter 6*2000ml
NDC:0941-0424-52

批次 Y344760，效期 12/2021，2箱
批次 Y341813，效期 11/2021，2箱
批次 Y341790，效期 11/2021，1箱
现货便宜处理